CDKL2 and breast cancer: Finally, we observed that CDKL2 is expressed significantly higher in mesenchymal subtypes of breast cancer cells, human MSC and fibroblasts than in epithelial subtypes (luminal and basal) of breast cancer cells, which strongly supports a role of CDKL2 in promoting EMT.